|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 222.48 USD | -5.18% |
|
-7.33% | +22.28% |
| 07:46am | Mizuho Trims Price Target on Axsome Therapeutics to $306 From $310, Keeps Outperform Rating | MT |
| 07-21 | BMO Capital Initiates Axsome Therapeutics at Outperform With $310 Price Target | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AXSOME THERAPEUTICS, INC. | Biopharmaceuticals | -5.32% | -7.33% | +22.28% | +120.29% | +343.83% | 12.07B |  |  | |
- Stock Market
- Stocks
- AXSM Stock
- Charts Axsome Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
